Androgen receptor expression on circulating tumor cells in metastatic breast cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen receptor expression on circulating tumor cells in metastatic breast cancer
Authors
Keywords
Breast cancer, Immunohistochemistry techniques, Biomarkers, Apoptosis, Cancer treatment, Cell staining, Prostate cancer, Androgens
Journal
PLoS One
Volume 12, Issue 9, Pages e0185231
Publisher
Public Library of Science (PLoS)
Online
2017-09-29
DOI
10.1371/journal.pone.0185231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
- (2016) Archana Anantharaman et al. BMC CANCER
- Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer
- (2016) Erik Hilborn et al. BRITISH JOURNAL OF CANCER
- Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis
- (2016) Stephanie B. Greene et al. PLoS One
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
- (2015) Elizabeth A Punnoose et al. BRITISH JOURNAL OF CANCER
- Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort
- (2015) K. Elebro et al. CLINICAL CANCER RESEARCH
- Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial
- (2015) Séverine Guiu et al. Future Oncology
- Androgen Receptor Expression Shows Distinctive Significance in ER Positive and Negative Breast Cancers
- (2014) Julia Y. S. Tsang et al. ANNALS OF SURGICAL ONCOLOGY
- PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer
- (2014) A. Markou et al. CLINICAL CANCER RESEARCH
- Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
- (2014) Jeffrey B. Smerage et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
- (2014) Edwin E Reyes et al. Journal of Translational Medicine
- Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
- (2014) Marta Pestrin et al. Molecular Oncology
- KAT6A, a Chromatin Modifier from the 8p11-p12 Amplicon is a Candidate Oncogene in Luminal Breast Cancer
- (2014) Brittany Turner-Ivey et al. NEOPLASIA
- Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer
- (2013) E S Lianidou et al. BRITISH JOURNAL OF CANCER
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) F. E. Vera-Badillo et al. JNCI-Journal of the National Cancer Institute
- Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver
- (2013) C Chang et al. ONCOGENE
- RSF1 and Not Cyclin D1 Gene Amplification May Predict Lack of Benefit from Adjuvant Tamoxifen in High-Risk Pre-Menopausal Women in the MA.12 Randomized Clinical Trial
- (2013) Dana Keilty et al. PLoS One
- Circulating Tumor Cells
- (2013) V. Plaks et al. SCIENCE
- Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
- (2012) Dena Marrinucci et al. PHYSICAL BIOLOGY
- Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
- (2011) R. Hu et al. CLINICAL CANCER RESEARCH
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
- (2011) Laura C Collins et al. MODERN PATHOLOGY
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
- (2010) Tanja Fehm et al. BREAST CANCER RESEARCH AND TREATMENT
- Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment
- (2010) Kiyoshi Takagi et al. ENDOCRINE-RELATED CANCER
- Cytomorphology of Circulating Colorectal Tumor Cells: A Small Case Series
- (2010) Dena Marrinucci et al. Journal of Oncology
- Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
- (2009) Francesca De Amicis et al. BREAST CANCER RESEARCH AND TREATMENT
- Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth
- (2009) A M Traish et al. BRITISH JOURNAL OF CANCER
- Androgen Receptor Inhibits Estrogen Receptor- Activity and Is Prognostic in Breast Cancer
- (2009) A. A. Peters et al. CANCER RESEARCH
- Cancer micrometastases
- (2009) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Are circulating tumor cells predictive of overall survival?
- (2009) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
- (2008) Steven J. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search